United Laboratories' antibiotic injection passes China regulatory evaluation

The United Laboratories International Holdings announced its Amoxicillin Sodium and Clavulanate Potassium for Injection has passed China's Consistency Evaluation by the National Medical Products Administration.

The broad-spectrum penicillin antibiotic is listed in China's National Essential Drug List and National Medical Insurance Drug List. The company expects the approval to strengthen its anti-infective market leadership.